{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:51:54Z","timestamp":1792007514664,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"self-raised project of Guangxi Zhuang Region Health Department","award":["Z2014446"],"award-info":[{"award-number":["Z2014446"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The eradication rate of <jats:italic>Helicobacter pylori<\/jats:italic> (<jats:italic>H. pylori<\/jats:italic>) has been decreasing every year, mainly due to the increase in antibiotic resistance. In fact, many other factors may affect <jats:italic>H. pylori<\/jats:italic> eradication. To analyze the clinical factors affecting the initial eradication therapy in Chinese patients with <jats:italic>H. pylori<\/jats:italic> infection. We conducted a retrospective study on 264 outpatients who were diagnosed with <jats:italic>H. pylori<\/jats:italic>-associated chronic gastritis and peptic ulcer disease between January and December 2015 at a large tertiary hospital in China. The patients were divided into three groups: ECA, RCA, and RCM (R: 20\u00a0mg rabeprazole, E: 40\u00a0mg esomeprazole, C: 0.5\u00a0g clarithromycin, A: 1.0\u00a0g amoxicillin and M: 0.4\u00a0g metronidazole). The patients were treated for 14\u00a0days and followed up for 1\u00a0year. The 14C-urea breath test (14C-UBT) was performed 4\u00a0weeks after the completion of the eradication therapy. The eradication rate was higher in\u2009\u2265\u200940-year-old patients than in\u2009&lt;\u200940-year-old-patients (85.7% vs. 54.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.002). Multivariate analyses revealed only age\u2009\u2265\u200940\u00a0years to be significantly associated with a high <jats:italic>H. pylori<\/jats:italic> eradication rate [odds ratio (OR) 4.58, <jats:italic>p<\/jats:italic>\u2009=\u20090.003]. The <jats:italic>H. pylori<\/jats:italic> eradication rate in patients with duodenal ulcers was significantly higher than that in patients with gastric ulcers (79% vs. 60%, <jats:italic>p<\/jats:italic>\u2009=\u20090.012). Age could be a predictor of successful <jats:italic>H. pylori<\/jats:italic> eradication. Patients with duodenal ulcers had a higher <jats:italic>H. pylori<\/jats:italic> eradication rate than those with other lesions.<\/jats:p>","DOI":"10.1038\/s41598-020-72400-0","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T10:03:11Z","timestamp":1600682591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China"],"prefix":"10.1038","volume":"10","author":[{"given":"Yanbo","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"issue":"Suppl 1","key":"72400_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12165","volume":"19","author":"LH Eusebi","year":"2014","unstructured":"Eusebi, L. H., Zagari, R. M. & Bazzoli, F. Epidemiology of Helicobacter pylori infection. Helicobacter 19(Suppl 1), 1\u20135 (2014).","journal-title":"Helicobacter"},{"key":"72400_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2458-5-118","volume":"5","author":"IS Santos","year":"2005","unstructured":"Santos, I. S. et al. Prevalence of Helicobacter pylori infection and associated factors among adults in Southern Brazil: a population-based cross-sectional study. BMC Public Health 5, 118 (2005).","journal-title":"BMC Public Health"},{"key":"72400_CR3","doi-asserted-by":"crossref","first-page":"e0140186","DOI":"10.1371\/journal.pone.0140186","volume":"10","author":"AF Syam","year":"2015","unstructured":"Syam, A. F. et al. Risk factors and prevalence of Helicobacter pylori in five largest islands of Indonesia: a preliminary study. PLoS ONE 10, e0140186 (2015).","journal-title":"PLoS ONE"},{"key":"72400_CR4","first-page":"112","volume":"10","author":"S Diaconu","year":"2017","unstructured":"Diaconu, S., Predescu, A., Moldoveanu, A., Pop, C. & Fierbin\u021beanu-Braticevici, C. Helicobacter pylori infection: old and new. J. Med. Life 10, 112\u2013117 (2017).","journal-title":"J. Med. Life"},{"key":"72400_CR5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1523-5378.2006.00459.x","volume":"11","author":"P Paoluzi","year":"2006","unstructured":"Paoluzi, P. et al. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study. Helicobacter 11, 562\u2013568 (2006).","journal-title":"Helicobacter"},{"key":"72400_CR6","first-page":"414","volume":"30","author":"T Rokkas","year":"2017","unstructured":"Rokkas, T., Rokka, A. & Portincasa, P. A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Ann. Gastroenterol. 30, 414\u2013423 (2017).","journal-title":"Ann. Gastroenterol."},{"key":"72400_CR7","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1158\/1078-0432.CCR-07-2022","volume":"14","author":"RH Argent","year":"2008","unstructured":"Argent, R. H. et al. Toxigenic Helicobacter pylori infection precedes gastric hypochlorhydria in cancer relatives, and H. pylori virulence evolves in these families. Clin. Cancer Res. 14, 2227\u20132235 (2008).","journal-title":"Clin. Cancer Res."},{"key":"72400_CR8","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/j.1572-0241.2005.00178.x","volume":"100","author":"JP Gisbert","year":"2005","unstructured":"Gisbert, J. P., Dom\u00ednguez-Mu\u00f1oz, A., Dom\u00ednguez-Mart\u00edn, A., Gisbert, J. L. & Marcos, S. Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?. Am. J. Gastroenterol. 100, 1935\u20131940 (2005).","journal-title":"Am. J. Gastroenterol."},{"key":"72400_CR9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/hel.12221","volume":"20","author":"SI Seo","year":"2015","unstructured":"Seo, S. I. et al. Is there any difference in the eradication rate of Helicobacter pylori infection according to the endoscopic stage of peptic ulcer disease?. Helicobacter 20, 424\u2013430 (2015).","journal-title":"Helicobacter"},{"key":"72400_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56399-7","volume":"9","author":"A Arenas","year":"2019","unstructured":"Arenas, A. et al. High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis. Sci. Rep. 9, 1\u20139 (2019).","journal-title":"Sci. Rep."},{"key":"72400_CR11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung, I. et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment. Pharmacol. Ther. 43, 514\u2013533 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"72400_CR12","doi-asserted-by":"crossref","first-page":"e2831","DOI":"10.1097\/MD.0000000000002831","volume":"95","author":"Z Ji","year":"2016","unstructured":"Ji, Z. et al. The association of age and antibiotic resistance of Helicobacter Pylori: a study in Jiaxing City, Zhejiang Province China. Medicine (Baltimore) 95, e2831 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"72400_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/S0004-28032013005000001","volume":"50","author":"LG Coelho","year":"2013","unstructured":"Coelho, L. G. et al. 3rd Brazilian consensus on Helicobacter pylori. Arq. Gastroenterol. 50, 81\u201396 (2013).","journal-title":"Arq. Gastroenterol."},{"key":"72400_CR14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner, P. et al. Management of Helicobacter pylori infection: the Maastricht IV\/Florence consensus report. Gut 61, 646\u2013664 (2012).","journal-title":"Gut"},{"key":"72400_CR15","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.3748\/wjg.v16.i33.4176","volume":"16","author":"S Mamori","year":"2010","unstructured":"Mamori, S. et al. Age-dependent eradication of Helicobacter pylori in Japanese patients. World J. Gastroenterol. 16, 4176\u20134179 (2010).","journal-title":"World J. Gastroenterol."},{"key":"72400_CR16","doi-asserted-by":"publisher","DOI":"10.1159\/000504909","author":"D Boltin","year":"2020","unstructured":"Boltin, D. et al. Comparative effect of proton-pump inhibitors on the success of triple and quadruple therapy for Helicobacter pylori infection. Dig. Dis. https:\/\/doi.org\/10.1159\/000504909 (2020).","journal-title":"Dig. Dis."},{"issue":"Suppl","key":"72400_CR17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bpg.2004.06.015","volume":"18","author":"A Pilotto","year":"2004","unstructured":"Pilotto, A. Aging and upper gastrointestinal disorders. Best Pract. Res. Clin. Gastroenterol. 18(Suppl), 73\u201381 (2004).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"72400_CR18","first-page":"58","volume":"14","author":"S Shakya Shrestha","year":"2016","unstructured":"Shakya Shrestha, S. et al. Medication adherence pattern and factors affecting adherence in Helicobacter Pylori eradication therapy. Kathmandu Univ. Med. J. (KUMJ) 14, 58\u201364 (2016).","journal-title":"Kathmandu Univ. Med. J. (KUMJ)"},{"key":"72400_CR19","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.3748\/wjg.v11.i47.7520","volume":"11","author":"I Shimbo","year":"2005","unstructured":"Shimbo, I. et al. Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. World J. Gastroenterol. 11, 7520\u20137524 (2005).","journal-title":"World J. Gastroenterol."},{"key":"72400_CR20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3164\/jcbn.16-86","volume":"60","author":"T Nishizawa","year":"2017","unstructured":"Nishizawa, T. et al. Effects of patient age and choice of antisecretory agent on success of eradication therapy for Helicobacter pylori infection. J. Clin. Biochem. Nutr. 60, 208\u2013210 (2017).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"72400_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/lsm.20770","volume":"41","author":"AJ Lembo","year":"2009","unstructured":"Lembo, A. J. et al. Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial. Lasers Surg. Med. 41, 337\u2013344 (2009).","journal-title":"Lasers Surg. Med."},{"key":"72400_CR22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12967-015-0558-1","volume":"13","author":"D Hu","year":"2015","unstructured":"Hu, D. et al. The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial. J. Transl. Med. 13, 205 (2015).","journal-title":"J. Transl. Med."},{"key":"72400_CR23","first-page":"238","volume":"37","author":"MC Camargo","year":"2007","unstructured":"Camargo, M. C. et al. Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia. Acta Gastroenterol. Latinoam. 37, 238\u2013245 (2007).","journal-title":"Acta Gastroenterol. Latinoam."},{"key":"72400_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2036.2003.01396.x","volume":"17","author":"N Broutet","year":"2003","unstructured":"Broutet, N. et al. Risk factors for failure of Helicobacter pylori therapy: results of an individual data analysis of 2751 patients. Aliment. Pharmacol. Ther. 17, 99\u2013109 (2003).","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72400-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72400-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72400-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:43:05Z","timestamp":1670355785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72400-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72400"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72400-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15403"}}